S&P 500   3,859.02 (+0.19%)
DOW   31,252.70 (+0.21%)
QQQ   325.20 (+0.44%)
AAPL   135.69 (+2.77%)
MSFT   224.81 (+0.21%)
FB   271.77 (+1.60%)
GOOGL   1,922.34 (+2.25%)
AMZN   3,329.28 (+2.02%)
TSLA   848.65 (-0.21%)
NVDA   542.45 (+1.46%)
BABA   260.27 (-1.97%)
CGC   33.44 (-0.56%)
GE   11.24 (-1.32%)
MU   83.45 (-0.06%)
AMD   90.29 (+1.74%)
NIO   56.60 (-1.92%)
T   28.78 (-0.62%)
F   11.37 (+4.70%)
ACB   11.12 (-3.64%)
BA   208.11 (-1.58%)
DIS   172.26 (-0.79%)
NFLX   578.00 (-1.42%)
GILD   66.80 (-1.75%)
S&P 500   3,859.02 (+0.19%)
DOW   31,252.70 (+0.21%)
QQQ   325.20 (+0.44%)
AAPL   135.69 (+2.77%)
MSFT   224.81 (+0.21%)
FB   271.77 (+1.60%)
GOOGL   1,922.34 (+2.25%)
AMZN   3,329.28 (+2.02%)
TSLA   848.65 (-0.21%)
NVDA   542.45 (+1.46%)
BABA   260.27 (-1.97%)
CGC   33.44 (-0.56%)
GE   11.24 (-1.32%)
MU   83.45 (-0.06%)
AMD   90.29 (+1.74%)
NIO   56.60 (-1.92%)
T   28.78 (-0.62%)
F   11.37 (+4.70%)
ACB   11.12 (-3.64%)
BA   208.11 (-1.58%)
DIS   172.26 (-0.79%)
NFLX   578.00 (-1.42%)
GILD   66.80 (-1.75%)
S&P 500   3,859.02 (+0.19%)
DOW   31,252.70 (+0.21%)
QQQ   325.20 (+0.44%)
AAPL   135.69 (+2.77%)
MSFT   224.81 (+0.21%)
FB   271.77 (+1.60%)
GOOGL   1,922.34 (+2.25%)
AMZN   3,329.28 (+2.02%)
TSLA   848.65 (-0.21%)
NVDA   542.45 (+1.46%)
BABA   260.27 (-1.97%)
CGC   33.44 (-0.56%)
GE   11.24 (-1.32%)
MU   83.45 (-0.06%)
AMD   90.29 (+1.74%)
NIO   56.60 (-1.92%)
T   28.78 (-0.62%)
F   11.37 (+4.70%)
ACB   11.12 (-3.64%)
BA   208.11 (-1.58%)
DIS   172.26 (-0.79%)
NFLX   578.00 (-1.42%)
GILD   66.80 (-1.75%)
S&P 500   3,859.02 (+0.19%)
DOW   31,252.70 (+0.21%)
QQQ   325.20 (+0.44%)
AAPL   135.69 (+2.77%)
MSFT   224.81 (+0.21%)
FB   271.77 (+1.60%)
GOOGL   1,922.34 (+2.25%)
AMZN   3,329.28 (+2.02%)
TSLA   848.65 (-0.21%)
NVDA   542.45 (+1.46%)
BABA   260.27 (-1.97%)
CGC   33.44 (-0.56%)
GE   11.24 (-1.32%)
MU   83.45 (-0.06%)
AMD   90.29 (+1.74%)
NIO   56.60 (-1.92%)
T   28.78 (-0.62%)
F   11.37 (+4.70%)
ACB   11.12 (-3.64%)
BA   208.11 (-1.58%)
DIS   172.26 (-0.79%)
NFLX   578.00 (-1.42%)
GILD   66.80 (-1.75%)
Log in
EPA:DIM

Sartorius Stedim Biotech S.A. (DIM.PA) Stock Forecast, Price & News

€318.40
+3.40 (+1.08 %)
(As of 01/20/2021 12:00 AM ET)
Add
Compare
Today's Range
€313.80
Now: €318.40▼
€322.00
50-Day Range
€287.00
MA: €295.14▼
€315.00
52-Week Range N/A
Volume62,658 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, filtration, purification, fluid management services, and membrane chromatography services. In addition, the company offers data analytics software for modeling and optimizing processed of biopharmaceutical development and production. It serves manufacturers of pharmaceuticals, foods, and chemicals, as well as research and development laboratories. The company was founded in 1870 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Sartorius Stedim Biotech S.A. (DIM.PA) logo

MarketRank™

Overall MarketRank™

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange EPA
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolEPA:DIM
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.sartorius.com
Phone33 4 42 84 56 00
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
€318.40
+3.40 (+1.08 %)
(As of 01/20/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DIM News and Ratings via Email

Sign-up to receive the latest news and ratings for DIM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sartorius Stedim Biotech S.A. (DIM.PA) (EPA:DIM) Frequently Asked Questions

How has Sartorius Stedim Biotech S.A. (DIM.PA)'s stock been impacted by COVID-19?

Sartorius Stedim Biotech S.A. (DIM.PA)'s stock was trading at €161.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, DIM stock has increased by 97.8% and is now trading at €318.40.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Sartorius Stedim Biotech S.A. (DIM.PA)?

Wall Street analysts have given Sartorius Stedim Biotech S.A. (DIM.PA) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sartorius Stedim Biotech S.A. (DIM.PA) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Sartorius Stedim Biotech S.A. (DIM.PA)'s key competitors?

Some companies that are related to Sartorius Stedim Biotech S.A. (DIM.PA) include Adherium Limited (ADR.AX) (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics Limited (AMT.AX) (AMT), Analytica Limited (ALT.AX) (ALT), AnteoTech Limited (ADO.AX) (ADO), Atomo Diagnostics Limited (AT1.AX) (AT1), AVITA Medical, Inc. (AVH.AX) (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), Cochlear (CHEOY), Cochlear (CHEOF), Cochlear Limited (COH.AX) (COH), Cyclopharm Limited (CYC.AX) (CYC), EMvision Medical Devices Limited (EMV.AX) (EMV) and Fisher & Paykel Healthcare Co. Limited (FPH.AX) (FPH).
View all of DIM's competitors.

What other stocks do shareholders of Sartorius Stedim Biotech S.A. (DIM.PA) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius Stedim Biotech S.A. (DIM.PA) investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Apellis Pharmaceuticals (APLS), Aquantia (AQ) and Aquinox Pharmaceuticals (AQXP).

Who are Sartorius Stedim Biotech S.A. (DIM.PA)'s key executives?

Sartorius Stedim Biotech S.A. (DIM.PA)'s management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman & CEO (Age 56, Pay $1.4M)
  • Mr. Heiko Imöhl, VP of Group Financing & Investor Relations
  • Ms. Petra Kirchhoff, Head of Corp. Communications & IR (Age 52)
  • Mr. John Gerard Mackay, Exec. VP of Marketing, Sales & Services for Lab Products and Services Division (Age 59)
  • Benedikt Orzelek, Head of Investor Relations

What is Sartorius Stedim Biotech S.A. (DIM.PA)'s stock symbol?

Sartorius Stedim Biotech S.A. (DIM.PA) trades on the EPA under the ticker symbol "DIM."

What is Sartorius Stedim Biotech S.A. (DIM.PA)'s stock price today?

One share of DIM stock can currently be purchased for approximately €318.40.

What is Sartorius Stedim Biotech S.A. (DIM.PA)'s official website?

The official website for Sartorius Stedim Biotech S.A. (DIM.PA) is www.sartorius.com.

How can I contact Sartorius Stedim Biotech S.A. (DIM.PA)?

The company can be reached via phone at 33 4 42 84 56 00.

This page was last updated on 1/21/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.